Aspirin targets key protein in neurodegenerative diseases

(Boyce Thompson Institute for Plant Research) The active ingredient in aspirin blocks an enzyme that triggers cell death in several neurodegenerative diseases. More potent forms of salicylic aspirin exist, which may provide treatments for these diseases.